Indonesia approves first home-grown Covid vaccine for emergency use

Indonesia approves first home-grown Covid vaccine for emergency use

FILE PHOTO: A child receives the Sinovac Covid-19 vaccine at an elementary school in Jakarta on Dec 15, 2021, as part of a government programme to vaccinate children aged 6 to 11. Indonesia has approved its first domestically-produced Covid-19 vaccine for emergency use for people over 18, media said on Wednesday. (AFP)
FILE PHOTO: A child receives the Sinovac Covid-19 vaccine at an elementary school in Jakarta on Dec 15, 2021, as part of a government programme to vaccinate children aged 6 to 11. Indonesia has approved its first domestically-produced Covid-19 vaccine for emergency use for people over 18, media said on Wednesday. (AFP)

JAKARTA: Indonesia has approved its first domestically-produced Covid-19 vaccine for emergency use for people over 18, the chief of the country's food and drugs agency (BPOM) was quoted by news media as saying on Wednesday.

The Indovac vaccine has been developed by Indonesia's state-owned pharmaceutical company Bio Farma and the Baylor College of Medicine in Houston, Texas.

Penny Lukito, the head of BPOM, was cited by news portal CNN Indonesia as saying the approval was "given as a primary vaccine for adults".

Penny and a Bio Farma spokesperson did not immediately respond to requests for comment.

Bio Farma said this month it would produce 20 million doses of the vaccine in 2022 and 100 million doses by 2024. It has also said it has sought a halal certificate - which would make the vaccine permissible under Islam - from relevant authorities.

Indonesia is the world's biggest Muslim-majority nation.

Bio Farma chief Honesti Basyir said earlier this month that the vaccines were intended to "help reduce the nation's dependency on imported vaccines," adding 80% of Indovac is locally-sourced.

Indonesia, which reported one of the highest transmission rates of Covid-19 in the world last year, has used vaccines produced by China's Sinovac Biotech, Pfizer Inc and BioNTech as well as Moderna Inc.

Bio Farma has said it has also sought an emergency use approval from the World Health Organization (WHO).


Do you like the content of this article?
COMMENT (3)

World Cup heavyweights gear up for quarter-finals

DOHA: Brazil, France and other World Cup heavyweights started the build-up to their quarter-final matches in earnest on Wednesday after Portugal made a huge statement of intent against Switzerland.

7 Dec 2022

Bali bombmaker released on parole from Indonesian prison: official

One of the bombmakers in the Bali blasts that killed more than 200 people two decades ago was released on parole on Wednesday, an Indonesian official said, months after Jakarta reduced his 20-year prison sentence.

7 Dec 2022

Time magazine names Ukraine's Zelensky 'Person of the Year'

NEW YORK: Time magazine named President Volodymyr Zelensky as well as "the spirit of Ukraine" as its 2022 person of the year on Wednesday, for the resistance the country has shown in the face of Russia's invasion.

7 Dec 2022